Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Astellas Pharma Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)